Tox21
Tox21 screens a chemical library to identify modulators of thyroid hormone receptors (TRs) and assess potential thyroid hormone disruption relevant to neurodevelopmental and reproductive toxicities.
Key Features:
- High-Throughput Screening: Screening of the Tox21 chemical collection comprising 8,305 unique structures to identify compounds that modulate TR activity as agonists or antagonists.
- Quantitative Reporter Gene Assay: Use of a quantitative high-throughput cell-based reporter gene assay to detect TR agonist and antagonist activities.
- Orthogonal Assays for Characterization: Active compounds are further characterized using mammalian one-hybrid assays, coactivator recruitment assays, and a high-throughput fluorescent imaging nuclear receptor translocation assay.
- Identification of Agonists and Indirect Activators: Recovery of known agonist reference chemicals and identification of a novel direct agonist, betamipron, with indirect TR activation detected via RXR agonist assays implicating the retinoid-X-receptor (RXR) heterodimer partner.
- Challenges in Antagonist Identification: Antagonist identification was confounded by cytotoxicity and non-TR-specific mechanisms in transactivation assays, although mefenamic acid, diclazuril, and risarestat were confirmed as antagonists.
Scientific Applications:
- Assessment of Structural Diversity: Evaluation of the structural diversity of environmentally relevant chemicals that can directly bind or modulate TRs.
- Prioritization of Thyroid Axis Targets: Evidence of limited structural diversity for direct TR ligands supports prioritizing other potential target sites within the thyroid hormone axis for bioactivity screening to identify thyroid axis disruptors.
Methodology:
An integrated approach combining quantitative high-throughput screening of the Tox21 chemical collection with multiple orthogonal assays (mammalian one-hybrid, coactivator recruitment, and nuclear receptor translocation assays) was used for characterization and validation of TR modulators.
Topics
Details
- Added:
- 11/14/2019
- Last Updated:
- 12/28/2020
Operations
Publications
Paul-Friedman K, Martin M, Crofton KM, Hsu C, Sakamuru S, Zhao J, Xia M, Huang R, Stavreva DA, Soni V, Varticovski L, Raziuddin R, Hager GL, Houck KA. Limited Chemical Structural Diversity Found to Modulate Thyroid Hormone Receptor in the Tox21 Chemical Library. Environmental Health Perspectives. 2019;127(9). doi:10.1289/ehp5314. PMID:31566444. PMCID:PMC6792352.